Daiwa Securities Group
MRTX

Daiwa Securities Group’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Daiwa Securities Group’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-287
Closed -$17K – 1371
2023
Q4 		$17K Buy
287
+55
+24% +$3.09K ﹤0.01% 1139
2023
Q3 		$10K Hold
232
– – ﹤0.01% 1129
2023
Q2 		$8K Hold
232
– – ﹤0.01% 1152
2023
Q1 		$9K Hold
232
– – ﹤0.01% 1119
2022
Q4 		$11K Buy
232
+25
+12% +$1.62K ﹤0.01% 1112
2022
Q3 		$14K Hold
207
– – ﹤0.01% 1113
2022
Q2 		$14K Buy
207
+46
+29% +$2.92K ﹤0.01% 1130
2022
Q1 		$13K Hold
161
– – ﹤0.01% 1127
2021
Q4 		$24K Sell
161
-16
-9% -$2.48K ﹤0.01% 1112
2021
Q3 		$31K Buy
177
+77
+77% +$12.4K ﹤0.01% 1084
2021
Q2 		$16K Hold
100
– – ﹤0.01% 1028
2021
Q1 		$17K Buy
100
+5
+5% +$990 ﹤0.01% 1017
2020
Q4 		$21K Sell
95
-154
-62% -$33.3K ﹤0.01% 980
2020
Q3 		$41K Buy
249
+7
+3% +$958 ﹤0.01% 949
2020
Q2 		$19K Hold
242
– – ﹤0.01% 1025
2020
Q1 		$19K Buy
242
+19
+9% +$1.7K ﹤0.01% 1009
2019
Q4 		$29K Sell
223
-27
-11% -$2.6K ﹤0.01% 992
2019
Q3 		$19K Buy
250
+26
+12% +$2.44K ﹤0.01% 999
2019
Q2 		$23K Hold
224
– – ﹤0.01% 1003
2019
Q1 		$16K Sell
224
-38
-15% -$2.58K ﹤0.01% 1002
2018
Q4 		$11K Buy
+262
New +$10.4K ﹤0.01% 994

Other funds holding MRTX

S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Daiwa Securities Group's MRTX Position: Q1 2024 in Review

Daiwa Securities Group sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 287 shares — an estimated $17K sold.

Daiwa Securities Group first reported a position in MRTX in Q4 2018 and held it in 21 quarters. The position peaked at $41K in Q3 2020. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.

  • Daiwa Securities Group reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Daiwa Securities Group sold 287 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $17K.
  • Daiwa Securities Group first reported a position in Mirati Therapeutics, Inc. Common Stock in Q4 2018 and held it in 21 quarters.
  • Daiwa Securities Group's Mirati Therapeutics, Inc. Common Stock position peaked at $41K in Q3 2020.
  • 2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Daiwa Securities Group's 13F filing for Q1 2024, filed 2 May 2024.